|
|
 |
| |
Psoriasis Cure Now releases new podcast discussing Remicade as a psoriasis treatment
(October 3, 2006) Psoriasis Cure Now, a nonprofit patient advocacy group, today released the newest in its series of psoriasis podcasts, this one focused on Remicade (infliximab) for the treatment of psoriasis. Last week, the U.S. Food and Drug Administration approved Centocor’s Remicade for the treatment of adults with severe psoriasis. The free podcast is available on the Psoriasis Cure Now website, or through iTunes.
The podcast includes a pair of interviews. Alan Menter, M.D., Chairman of the Division of Dermatology at Baylor University Medical Center and a renowned dermatologist, speaks about Remicade’s efficacy and safety profile. Dr. Menter was the lead investigator for Remicade’s U.S. psoriasis study. The podcast also includes an interview with Mike Hills, a Remicade patient from Virginia, who shares his experience with the treatment and walks us through an infusion from the patient perspective. Remicade is delivered via intravenous infusion in a medical setting, a procedure with which many patients are not yet familiar.
“Remicade is an important new treatment option for people with severe psoriasis, so we put together interviews with a top psoriasis expert and a man treating his psoriasis with Remicade to help people understand what Remicade is and whether it might be appropriate for them,” said Michael Paranzino, president of Psoriasis Cure Now. “That psoriasis patient waited a quarter century to clear his skin, and many psoriasis patients have been waiting even longer than that. People who are not satisfied with their current condition owe it to themselves to speak with their physician about all the new treatment options that have appeared in recent years.”
Remicade is also approved for several other diseases, including psoriatic arthritis, rheumatoid arthritis and Crohn’s disease. Previous Psoriasis Cure Now podcasts have covered topics including strategies for treating children with psoriasis, and the future of psoriasis treatments. The next one, to be released near the end of October, will be an introduction to psoriatic arthritis. They are all available free from the Psoriasis Cure Now website and via iTunes.
|
|
|
|
